Andrew Callos - Net Worth and Insider Trading

Andrew Callos Net Worth

The estimated net worth of Andrew Callos is at least $2 Million dollars as of 2025-07-21. Andrew Callos is the EVP, Chief Commercial Officer of Cytokinetics Inc and owns about 52,028 shares of Cytokinetics Inc (CYTK) stock worth over $2 Million. Details can be seen in Andrew Callos's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Callos has not made any transactions after 2025-06-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Andrew Callos

To

Andrew Callos Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew Callos owns 1 companies in total, including Cytokinetics Inc (CYTK) .

Click here to see the complete history of Andrew Callos’s form 4 insider trades.

Insider Ownership Summary of Andrew Callos

Ticker Company Transaction Date Type of Owner
CYTK Cytokinetics Inc 2025-06-05 EVP & Chief Commercial Officers

Andrew Callos Latest Holdings Summary

Andrew Callos currently owns a total of 1 stock. Andrew Callos owns 52,028 shares of Cytokinetics Inc (CYTK) as of June 5, 2025, with a value of $2 Million.

Latest Holdings of Andrew Callos

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CYTK Cytokinetics Inc 2025-06-05 52,028 37.23 1,937,002

Holding Weightings of Andrew Callos


Andrew Callos Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew Callos has made a total of 9 transactions in Cytokinetics Inc (CYTK) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Cytokinetics Inc is the sale of 8,659 shares on June 5, 2025, which brought Andrew Callos around $277,434.

Insider Trading History of Andrew Callos

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew Callos Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Andrew Callos Ownership Network

Ownership Network List of Andrew Callos

No Data

Ownership Network Relation of Andrew Callos

Insider Network Chart


Andrew Callos Owned Company Details

What does Cytokinetics Inc do?

Who are the key executives at Cytokinetics Inc?

Andrew Callos is the EVP & Chief Commercial Officers of Cytokinetics Inc. Other key executives at Cytokinetics Inc include EVP & Corp. Development & CBO Robert I Blum , SVP Research & Early Dev Fady Ibraham Malik , and VP & Chief Accounting Officer Robert Wong .

Cytokinetics Inc (CYTK) Insider Trades Summary

Over the past 18 months, Andrew Callos made 9 insider transaction in Cytokinetics Inc (CYTK) with a net sale of 70,548. Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 223,637 shares made by Fady Ibraham Malik , a net sale of 271,861 shares made by Robert I Blum , and a net sale of 40,000 shares made by B Lynne Parshall .

In summary, during the past 3 months, insiders sold 54,751 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 54,751 shares. During the past 18 months, 674,898 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 674,898 shares.

Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cytokinetics Inc Insider Transactions

No Available Data

Andrew Callos Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew Callos. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Andrew Callos's mailing address is: South San Francisco Ca 94080.